You have 9 free searches left this month | for more free features.

Fibroblast activating protein inhibitor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)

Recruiting
  • Lupus Nephritis
  • 68Ga-FAPI-04 PET
  • Shanghai, China
    Ruijin Hospital
May 4, 2023

Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission

Recruiting
  • Solid Tumor, Unspecified, Adult
  • 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
  • Meldola, Forlì Cesena, Italy
    IRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
Nov 15, 2023

Myositis, Idiopathic Inflammatory Myopathies Trial in Xiamen (68Ga-FAPI)

Recruiting
  • Myositis
  • Idiopathic Inflammatory Myopathies
  • Xiamen, Fujian, China
    The first affiliated hospital of Xiamen University
Jul 12, 2023

18F-FAPI PET/CT Examination, Renal Puncture Biopsy Trial ([18F]AlF-NOTA-FAPI-04 PET/CT examination, Renal puncture biopsy)

Not yet recruiting
  • 18F-FAPI PET/CT Examination
  • Renal Puncture Biopsy
  • [18F]AlF-NOTA-FAPI-04 PET/CT examination
  • Renal puncture biopsy
  • (no location specified)
Mar 1, 2023

Psoriatic Arthritis Trial in Beijing (68Ga-FAPI)

Recruiting
  • Psoriatic Arthritis
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Jan 7, 2023

Fibroblast Activation Protein Inhibitor PET/CT Imaging in

Recruiting
  • Gastrointestinal Cancer
  • Fibroblast activation protein inhibitor PET/CT imaging
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 14, 2022

Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

Recruiting
  • Malignant Tumor
  • +2 more
  • 68Ga-TCR-FAPI PET/CT
  • Beijing, China
    Peking University Cancer Hospital
Oct 19, 2023

Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)

Recruiting
  • Cancer
  • Peritoneal Carcinomatosis
  • FAPI PET/CT
  • Brussels, Belgium
    Institut Jules Bordet
Sep 25, 2023

Renal Tumor Trial

Not yet recruiting
  • Renal Tumor
    • (no location specified)
    Aug 2, 2023

    Malignant Tumor Trial in Wuhan (68Ga-DOTA-FAPI, PET/MR, PET/CT)

    Recruiting
    • Malignant Neoplasm
    • Wuhan, Hubei, China
      China, Hubei Province
    Feb 9, 2022

    Rheumatoid Arthritis Trial

    Not yet recruiting
    • Rheumatoid Arthritis
      • (no location specified)
      Jul 6, 2023

      Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis Trial in Xiamen (Drug: 68Ga-FAPI)

      Recruiting
      • Spondyloarthritis
      • +2 more
      • Drug: 68Ga-FAPI
      • Xiamen, Fujian, China
        The first affiliated hospital of Xiamen University
      Aug 13, 2023

      18F-FAPI-RGD in Interstitial Lung Disease Associated With

      Recruiting
      • Interstitial Lung Disease
        • Chengdu, Sichuan, China
          Sichuan Provincial People's Hospital
        Nov 21, 2023

        Breast Tumors Trial

        Not yet recruiting
        • Breast Tumors
          • (no location specified)
          Aug 2, 2023

          Atherosclerosis Trial in Beijing (68Ga-FAPI)

          Recruiting
          • Atherosclerosis
          • Beijing, China
            Peking Union Medical College Hospital
          Sep 6, 2021

          Pulmonary Fibrosis Trial in Beijing (68Ga-FAPI, 18F-FDG)

          Not yet recruiting
          • Pulmonary Fibrosis
          • Beijing, Beijing, China
            Peking Union Medical College Hospital
          Nov 4, 2021

          Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

          Recruiting
          • Refractory Thyroid Gland Carcinoma
          • +3 more
          • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
          • +2 more
          • Xiamen, China
            The First Affiliated Hospital of Xiamen University
          Nov 3, 2022

          Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)

          Recruiting
          • Fibroblast Activation Protein Inhibitor
          • +2 more
          • Wuhan, Hubei, China
            Zhongnan Hospital of Wuhan University
          Aug 27, 2021

          Cancer Trial in Stanford (68Ga-FAPI, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan)

          Not yet recruiting
          • Cancer
          • Stanford, California
            Stanford University Hospitals and Clinics
          Nov 9, 2022

          Tumor, Solid Trial in Beijing (68Ga-DOTA-F2 PET/CT and 18F-FDG)

          Recruiting
          • Tumor, Solid
          • 68Ga-DOTA-F2 PET/CT and 18F-FDG
          • Beijing, Beijing, China
            Peking union medical college hospital
          Nov 27, 2022

          Keloid Trial in Beijing (68Ga-FAPI, (68)Ga-RGD)

          Recruiting
          • Keloid
          • Beijing, Beijing, China
            Peking Union Medical College Hospital
          Mar 2, 2022

          68Ga-FAPI PET/CT, Metastatic Adenoid Cystic Carcinoma Trial in Beijing (68Ga-FAPI)

          Recruiting
          • 68Ga-FAPI PET/CT
          • Metastatic Adenoid Cystic Carcinoma
          • Beijing, China
            Peking Union Medical College Hospital, Chinese Academy of Medica
          Aug 10, 2022

          Pancreatic Tumors, Stomach Tumors, Bile Duct Tumors Trial in Stockholm (68Ga-FAPI-46, PET/CT)

          Recruiting
          • Pancreatic Neoplasms
          • +3 more
          • Stockholm, Sweden
            Karolinska University Hospital Huddinge
          Dec 13, 2021

          Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)

          Recruiting
          • Breast Neoplasms
          • +3 more
          • 68Ga-FAPI-46 PET/CT
          • Baku, Azerbaijan
            National Centre of Oncology
          Jun 21, 2022

          PET/CT, FAPI, Oral Cancer Trial in Wuhan (68Ga-DOTA-FAPI, PET/CT)

          Recruiting
          • PET/CT
          • +2 more
          • Wuhan, Hubei, China
            Zhongnan Hopital of Wuhan University
          Dec 30, 2021